The Benchmark Company raised the price target for the Aspen Aerogels Inc. (NYSE:ASPN) stock to ‘a Buy’. The rating was released on December 10, 2021, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $58. The stock was initiated by Oppenheimer, who disclosed in a research note on June 17, 2021, to Outperform and set the price objective to $51. In their research brief published June 15, 2021, Seaport Global Securities analysts initiated the Aspen Aerogels Inc.